+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast 2026-2032- Product Image
Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast 2026-2032- Product Image
Sale

Bird Flu Treatment Market by Product Type, Administration Route, End User, Application - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010916
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bird Flu Treatment Market is projected to reach USD 13.31 Billion in 2026. It is expected to continue growing at a CAGR of 6.72%, reaching USD 19.75 Billion by 2032.

Bird flu treatment is moving from an episodic public health concern to a strategic priority for governments, pharmaceutical manufacturers, healthcare systems, and animal health stakeholders. Human infections with avian influenza A viruses such as H5N1, H7N9, and other zoonotic subtypes remain uncommon, but the clinical stakes are high: WHO surveillance has documented more than 900 human H5N1 cases since 2003, with historically high case fatality among reported infections.

Current treatment strategies emphasize rapid antiviral initiation, supportive clinical care, infection prevention, and coordinated One Health surveillance across poultry, wild birds, mammals, and humans. The market demand is being shaped by neuraminidase inhibitors such as oseltamivir, zanamivir, and peramivir, investigational therapeutics, diagnostic testing, antiviral stockpiling, and pandemic preparedness programs.

Transformative Shifts in Bird Flu Treatment

The bird flu treatment landscape is being reshaped by wider geographic spread of highly pathogenic avian influenza, growing mammalian detections, and heightened concern over zoonotic spillover. Since 2021, H5N1 clade 2.3.4.4b has driven extensive outbreaks in wild birds and poultry across multiple regions, increasing demand for faster detection, early treatment protocols, and stronger antiviral readiness.

Treatment pathways are also shifting from hospital-centered response to integrated preparedness. Governments and health systems are strengthening antiviral reserves, updating clinical guidance, expanding sequencing capacity, and connecting veterinary surveillance with human health alert systems. This transition is creating new opportunities for antiviral manufacturers, diagnostic developers, cold-chain providers, and clinical research organizations.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly important in avian influenza response because treatment decisions depend on speed, subtype identification, and risk assessment. AI-enabled genomic surveillance can help flag mutations associated with mammalian adaptation, antiviral resistance, or antigenic drift, allowing public health agencies and manufacturers to prioritize candidate countermeasures more efficiently.

In clinical and commercial settings, AI can support outbreak forecasting, hospital triage workflows, drug repurposing, pharmacovigilance, and supply planning for antivirals and diagnostics. The cumulative impact is strongest when AI outputs are validated against laboratory-confirmed data, transparent epidemiological models, and regulatory-grade evidence rather than used as stand-alone decision tools.

Key Regional Insights

Asia-Pacific remains a critical region for bird flu treatment because it has experienced repeated human infections linked to avian influenza subtypes, including H5N1 and H7N9, alongside dense poultry production, live bird market exposure, and high-volume regional trade in several countries. North America has intensified preparedness following widespread H5N1 detections in wild birds, poultry, mammals, and U.S. dairy cattle, increasing emphasis on occupational monitoring, antivirals, diagnostic access, and risk communication for exposed workers.

Europe continues to invest in surveillance and cross-border response through public health and animal health coordination, while Latin America has expanded attention to poultry protection, wildlife monitoring, and treatment readiness after regional H5N1 incursions in birds and marine mammals. The Middle East’s risk profile is linked to migratory bird routes, poultry imports, live animal movement, and healthcare preparedness, whereas Africa faces added challenges from limited laboratory capacity, uneven antiviral availability, underreported outbreaks, and the need for stronger One Health infrastructure.

Key Group Insights

ASEAN markets are central to bird flu treatment demand because poultry density, cross-border trade, live bird market interfaces, and historical avian influenza outbreaks require integrated surveillance and rapid access to antivirals. The GCC is prioritizing health security, import controls, hospital preparedness, and high-capacity public-sector procurement, supported by interest in advanced diagnostics and coordinated emergency response systems.

The European Union benefits from harmonized animal disease reporting, centralized regulatory pathways, coordinated preparedness planning, and established laboratory networks, making it a major reference point for avian influenza response standards. BRICS countries represent a large treatment opportunity due to population scale, poultry production intensity, vaccine and pharmaceutical manufacturing capacity, and varied exposure to poultry and wildlife reservoirs. G7 and NATO members influence antiviral stockpiling, research funding, biosurveillance interoperability, supply chain resilience, and emergency response coordination across allied healthcare, agriculture, and defense systems.

Key Country Insights

The United States is prioritizing H5N1 surveillance, antiviral guidance, occupational risk monitoring, and coordination between public health, agriculture, and dairy operations, while Canada is focused on wildlife, poultry, and public health coordination supported by national surveillance systems. Mexico and Brazil are important due to poultry production scale, regional trade exposure, and the need to protect food supply chains. The United Kingdom, Germany, France, Italy, and Spain continue to strengthen surveillance, laboratory capacity, antiviral readiness, and preparedness through European public health and animal health frameworks.

Russia’s geographic scale, poultry sector, and migratory bird pathways make monitoring strategically important. China and India combine large poultry sectors, dense population interfaces, prior avian influenza experience, and substantial domestic pharmaceutical capacity, making them central to treatment access and outbreak control. Japan, Australia, and South Korea maintain advanced diagnostics, strict biosecurity, national stockpiling policies, and strong public health systems that support rapid clinical response, subtype confirmation, and antiviral deployment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based antiviral portfolios, scalable manufacturing, and resilient supply chains for oseltamivir and other clinically relevant influenza therapeutics. Companies should align product strategy with CDC, WHO, and national clinical guidance emphasizing early treatment for suspected or confirmed human avian influenza, particularly among patients with high-risk exposure, severe disease, or occupational contact with infected animals.

Executives should invest in companion diagnostics, resistance monitoring, genomic surveillance partnerships, and real-world evidence generation. Commercial teams can strengthen market positioning by supporting government stockpiles, hospital protocols, occupational health programs, pharmacist education, cold-chain readiness, and One Health collaborations that connect poultry producers, veterinarians, laboratories, and public health agencies.

Research Methodology

This executive summary is based on secondary research from verified public health, regulatory, and scientific sources, including WHO, CDC, WOAH, FAO, national health agencies, peer-reviewed literature, and official surveillance updates. The analysis emphasizes clinically accepted treatment approaches, documented outbreak patterns, regional preparedness indicators, antiviral resistance considerations, diagnostic capacity, and publicly available evidence on avian influenza epidemiology.

The methodology applies a structured market intelligence framework that triangulates disease surveillance, treatment guidance, policy developments, procurement behavior, technology adoption, and One Health response priorities. Insights are synthesized to support strategic planning across pharmaceuticals, diagnostics, healthcare delivery, animal health, and government preparedness without relying on speculative or unverified claims.

Conclusion

Bird flu treatment demand is being driven by the convergence of zoonotic risk, expanding surveillance, antiviral preparedness, and the need for faster clinical response. Although human cases remain rare, the severity of reported infections and the global spread of highly pathogenic avian influenza justify sustained investment in therapeutics, diagnostics, stockpiling, and One Health infrastructure.

The strongest market opportunities will favor organizations that combine regulatory readiness, scientific credibility, scalable production, validated diagnostics, and public-sector collaboration. As AI, genomic sequencing, and integrated surveillance mature, the bird flu treatment landscape is expected to become more proactive, data-driven, and preparedness-oriented.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bird Flu Treatment Market, by Product Type
7.1. Antiviral Drug
7.1.1. Adamantanes
7.1.2. Combination Therapy
7.1.3. Neuraminidase Inhibitors
7.1.4. Polymerase Inhibitors
7.2. Supportive Care
7.2.1. Oxygen Therapy
7.2.2. Rehydration Therapy
7.2.3. Symptom Management
7.2.4. Telehealth Monitoring
7.3. Vaccine
7.3.1. Inactivated Vaccine
7.3.2. Live Attenuated Vaccine
7.3.3. Mrna Vaccine
7.3.4. Recombinant Vaccine
8. Bird Flu Treatment Market, by Administration Route
8.1. Inhalation
8.1.1. Dry Powder Inhaler
8.1.2. Metered Dose Inhaler
8.1.3. Nebulizer
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Nanoparticle Delivery
8.2.3. Subcutaneous
8.3. Intravenous
8.3.1. Central Line
8.3.2. Peripheral Line
8.3.3. Smart Infusion Pumps
8.4. Oral
8.4.1. Capsule
8.4.2. Sublingual
8.4.3. Suspension
8.4.4. Tablet
9. Bird Flu Treatment Market, by End User
9.1. Clinics
9.1.1. Community Health Centers
9.1.2. Outpatient Clinics
9.1.3. Specialty Clinics
9.2. Hospitals
9.2.1. Private Hospitals
9.2.2. Public Hospitals
9.2.3. Specialized Care Centers
9.3. Laboratories
9.3.1. Hospital Labs
9.3.2. Independent Labs
9.3.3. Point Of Care Testing
9.4. Pharmacies
9.4.1. Mail Order Pharmacies
9.4.2. Online Pharmacies
9.4.3. Retail Pharmacies
10. Bird Flu Treatment Market, by Application
10.1. Animal Health
10.1.1. Livestock
10.1.2. Poultry
10.1.3. Wild Birds
10.2. Human Health
10.2.1. Adult Patients
10.2.2. Geriatric Patients
10.2.3. Pediatric Patients
11. Asia-Pacific Bird Flu Treatment Market
12. Europe Bird Flu Treatment Market
13. North America Bird Flu Treatment Market
14. Latin America Bird Flu Treatment Market
15. Africa Bird Flu Treatment Market
16. Middle East Bird Flu Treatment Market
17. NATO Bird Flu Treatment Market
18. G7 Bird Flu Treatment Market
19. BRICS Bird Flu Treatment Market
20. European Union Bird Flu Treatment Market
21. ASEAN Bird Flu Treatment Market
22. GCC Bird Flu Treatment Market
23. China Bird Flu Treatment Market
24. United States Bird Flu Treatment Market
25. Japan Bird Flu Treatment Market
26. India Bird Flu Treatment Market
27. Germany Bird Flu Treatment Market
28. United Kingdom Bird Flu Treatment Market
29. Australia Bird Flu Treatment Market
30. France Bird Flu Treatment Market
31. South Korea Bird Flu Treatment Market
32. Italy Bird Flu Treatment Market
33. Canada Bird Flu Treatment Market
34. Russia Bird Flu Treatment Market
35. Brazil Bird Flu Treatment Market
36. Mexico Bird Flu Treatment Market
37. Spain Bird Flu Treatment Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. Alltech, Inc.
39.2. BioCryst Pharmaceuticals, Inc.
39.3. Boehringer Ingelheim International GmbH
39.4. Ceva Santé Animale
39.5. Cipla Limited
39.6. CSL Limited
39.7. F. Hoffmann-La Roche Ltd.
39.8. FATRO S.p.A.
39.9. Gilead Sciences, Inc.
39.10. GlaxoSmithKline PLC
39.11. Hester Biosciences Limited
39.12. Johnson & Johnson Services, Inc.
39.13. Macleods Pharmaceuticals Ltd
39.14. Merck KGaA
39.15. Moderna, Inc.
39.16. Novartis AG
39.17. PetSmart LLC
39.18. Pfizer Inc.
39.19. Sanofi S.A.
39.20. Serum Institute of India Pvt. Ltd.
39.21. Sinovac Biotech Ltd.
39.22. Takeda Pharmaceutical Company Limited
39.23. Tianjin Ringpu Biotechnology Co. Ltd.
39.24. Yebio Bioengineering Co. Ltd.
39.25. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL BIRD FLU TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIRD FLU TREATMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIRD FLU TREATMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIRD FLU TREATMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. NATO BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. NATO BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. G7 BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. G7 BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. BRICS BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. BRICS BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. CHINA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. UNITED STATES BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. JAPAN BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. INDIA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED KINGDOM BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. AUSTRALIA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. FRANCE BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. SOUTH KOREA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. ITALY BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CANADA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. RUSSIA BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. BRAZIL BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIRD FLU TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIRD FLU TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIRD FLU TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL BIRD FLU TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIVIRAL DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIVIRAL DRUG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIVIRAL DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ADAMANTANES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ADAMANTANES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ADAMANTANES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMBINATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMBINATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COMBINATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEURAMINIDASE INHIBITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEURAMINIDASE INHIBITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEURAMINIDASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL POLYMERASE INHIBITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL POLYMERASE INHIBITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL POLYMERASE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SUPPORTIVE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SUPPORTIVE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SUPPORTIVE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OXYGEN THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OXYGEN THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OXYGEN THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL REHYDRATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL REHYDRATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL REHYDRATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SYMPTOM MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TELEHEALTH MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TELEHEALTH MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TELEHEALTH MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MRNA VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MRNA VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MRNA VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRY POWDER INHALER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRY POWDER INHALER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRY POWDER INHALER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL METERED DOSE INHALER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL METERED DOSE INHALER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL METERED DOSE INHALER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEBULIZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEBULIZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NANOPARTICLE DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NANOPARTICLE DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NANOPARTICLE DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CENTRAL LINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CENTRAL LINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CENTRAL LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PERIPHERAL LINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PERIPHERAL LINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PERIPHERAL LINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SMART INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SMART INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SMART INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CAPSULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CAPSULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SUBLINGUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL SUBLINGUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL SUBLINGUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL SUSPENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL SUSPENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SUSPENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TABLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TABLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TABLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COMMUNITY HEALTH CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COMMUNITY HEALTH CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL COMMUNITY HEALTH CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL SPECIALIZED CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL SPECIALIZED CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL SPECIALIZED CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL HOSPITAL LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITAL LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITAL LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL MAIL ORDER PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL MAIL ORDER PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL MAIL ORDER PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL WILD BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL WILD BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL WILD BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL HUMAN HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL HUMAN HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL HUMAN HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ADULT PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ADULT PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ADULT PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL GERIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL PEDIATRIC PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 198. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 201. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 203. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 204. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 205. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 208. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 210. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 211. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 212. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 213. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 215. EUROPE BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 252. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 253. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 255. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 256. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 257. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 258. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 259. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 260. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 261. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 262. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 264. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 265. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 266. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 267. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 269. AFRICA BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 288. NATO BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 289. NATO BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. NATO BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 291. NATO BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 292. NATO BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 293. NATO BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 294. NATO BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 295. NATO BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 296. NATO BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 297. NATO BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 298. NATO BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. NATO BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 300. NATO BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 301. NATO BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 302. NATO BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 303. NATO BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 304. NATO BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 305. NATO BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 306. G7 BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 307. G7 BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 308. G7 BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 309. G7 BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 310. G7 BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 311. G7 BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 312. G7 BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 313. G7 BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 314. G7 BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 315. G7 BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 316. G7 BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. G7 BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 318. G7 BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 319. G7 BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 320. G7 BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 321. G7 BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 322. G7 BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 323. G7 BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 324. BRICS BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 325. BRICS BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 326. BRICS BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 327. BRICS BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 328. BRICS BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 329. BRICS BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 330. BRICS BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 331. BRICS BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 332. BRICS BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 333. BRICS BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 334. BRICS BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 335. BRICS BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 336. BRICS BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 337. BRICS BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 338. BRICS BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 339. BRICS BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 340. BRICS BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 341. BRICS BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 342. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 343. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 344. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 345. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 346. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 347. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 348. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 349. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 350. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 351. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 352. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 353. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 354. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 355. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 356. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 357. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 358. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 359. EUROPEAN UNION BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 360. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 361. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 362. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY ANTIVIRAL DRUG, 2018-2032 (USD MILLION)
TABLE 363. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2032 (USD MILLION)
TABLE 364. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 365. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
TABLE 366. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 367. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 368. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 369. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 370. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 371. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 372. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 373. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 374. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 375. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 376. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY ANIMAL HEALTH, 2018-2032 (USD MILLION)
TABLE 377. ASEAN BIRD FLU TREATMENT MARKET SIZE, BY HUMAN HEALTH, 2018-2032 (USD MILLION)
TABLE 378. GCC BIRD FLU TREATMEN

Companies Mentioned

The companies featured in this Bird Flu Treatment market report include:
  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Cipla Limited
  • CSL Limited
  • F. Hoffmann-La Roche Ltd.
  • FATRO S.p.A.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hester Biosciences Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Ltd
  • Merck KGaA
  • Moderna, Inc.
  • Novartis AG
  • PetSmart LLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Tianjin Ringpu Biotechnology Co. Ltd.
  • Yebio Bioengineering Co. Ltd.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.75 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Bird Flu Treatment Market - Global Strategic Business Report - Product Image

Bird Flu Treatment Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Common Cold Market Report and Forecast 2025-2034 - Product Image

Common Cold Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Oseltamivir Phosphate Granules Market - Global Forecast 2025-2030 - Product Image

Oseltamivir Phosphate Granules Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cold and Flu Drugs Market Report 2026 - Product Image

Cold and Flu Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Seasonal Influenza Market Report 2026 - Product Image

Seasonal Influenza Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Avian Influenza Drug Market

The Avian Influenza Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat avian influenza, a type of influenza virus that primarily affects birds, but can also infect humans. These drugs are used to reduce the severity of symptoms and prevent further spread of the virus. They are typically administered in the form of antiviral medications, such as oseltamivir and zanamivir. Vaccines are also available to help protect against avian influenza. The Avian Influenza Drug market is highly competitive, with many companies offering products to treat the virus. Some of the major players in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Other companies, such as Cipla, Mylan, and Sun Pharmaceuticals, also offer products for the treatment of avian influenza. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.